Life Sciences Times

cTAP Publishes Prognostic Score to Predict Loss of Ambulation in Duchenne Muscular Dystrophy

Alkermes Gets Orphan Drug Designations for Alixorexton in U.S., Europe

Heartseed Doses First Patient in Trial of Catheter-Delivered iPSC-Derived Cardiomyocyte Spheroids

Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Bundibugyo Outbreak Response in Africa

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL for Cataract Patients

N-Zyme Biomedical Begins Phase 2 Trial of Pepsin Inhibitor for Reflux Disease

SonoThera Raises $125 Million to Advance Nonviral Genetic Medicine Programs

ValGenesis Hosts ValConnect Innovation Day Events in Lisbon and North Carolina

GENESIS Pharma Expands Alnylam Partnership to Nordic Region

Chiesi Completes Acquisition of KalVista Pharmaceuticals